Mutational analysis of the active site and antibody epitopes of the complement-inhibitory glycoprotein, CD59
Bodian DL, Davis SJ, Morgan BP, Rushmere NK. (1997), J Exp Med. 185, 507-16
The glycosylation of the complement regulatory protein, human erythrocyte CD59
Rudd PM, Morgan BP, Wormald MR, Harvey DJ, van den Berg CW, Davis SJ, Ferguson MA, Dwek RA. (1997), J Biol Chem. 272, 7229-44
NMR analysis of interacting soluble forms of the cell-cell recognition molecules CD2 and CD48
McAlister MS, Mott HR, van der Merwe PA, Campbell ID, Davis SJ, Driscoll PC. (1996), Biochemistry. 35, 5982-91
CD2: an exception to the immunoglobulin superfamily concept?
Davis SJ, van der Merwe PA. (1996), Science. 273, 1241-2
The structure and ligand interactions of CD2: implications for T-cell function
Davis SJ, van der Merwe PA. (1996), Immunol Today. 17, 177-87
Mutational analysis of the epitopes recognized by anti-(rat CD2) and anti-(rat CD48) monoclonal antibodies
Davis SJ, Davies EA, van der Merwe PA. (1995), Biochem Soc Trans. 23, 188-94
Topology of the CD2-CD48 cell-adhesion molecule complex: implications for antigen recognition by T cells
van der Merwe PA, McNamee PN, Davies EA, Barclay AN, Davis SJ. (1995), Curr Biol. 5, 74-84
Ligand binding by the immunoglobulin superfamily recognition molecule CD2 is glycosylation-independent
Davis SJ, Davies EA, Barclay AN, Daenke S, Bodian DL, Jones EY, Stuart DI, Butters TD, Dwek RA, van der Merwe PA. (1995), J Biol Chem. 270, 369-75
Estimation of the dissociation constant of the cell adhesion molecules srCD2 and srCD48 using analytical ultracentrifugation
Silkowski H, Byron O, Davis SJ, Barclay AN, Davies EA, Rowe AJ, Harding SE. (1995), Biochem Soc Trans. 23, 435S
The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding
Fischer PB, Collin M, Karlsson GB, James W, Butters TD, Davis SJ, Gordon S, Dwek RA, Platt FM. (1995), J Virol. 69, 5791-7